Mitch Lamb, PharmD, joins Over the Counter to discuss pharmacy accreditation hurdles and why staying consistently proactive can mean the world for a pharmacy's bottom line.

Cencora representatives Matt Sample and Neal Cooper join Over the Counter to discuss the FDA's 7-year push to move national drug codes from 10 to 12 universal digits.

Walgreens Chief Pharmacy Officer Rick Gates joins Over the Counter to discuss his organization's newly introduced hybrid pharmacist role and how it is creating innovation across the greater pharmacy industry.

Sylvie Stacy, MD, MPH, joins Over the Counter to discuss the emerging evidence regarding GLP-1s for various types of substance use disorders and the potential role this medication class can play for millions of vulnerable patients.

Mark Garofoli, PharmD, BCGP, CPE, CTTS, joins Over the Counter to discuss recent comments from FDA Commissioner Marty Makary, MD, MPH, and what they could mean for the pharmacy profession going forward.

William A. Bryson, PharmD, joins Over the Counter for a bonus rendition celebrating Diabetes Alert Day on March 24.

Annie Lambert, PharmD, BCSCP, joins Over the Counter to discuss the safety and scrutiny of compounded GLP-1s and the pharmacist's role in helping patients understand their clinical impact.

Lani Bertrand, senior director of clinical marketing & thought leadership at Omnicell, joins Over the Counter to discuss the constant challenges pharmacies are faced with regarding drug shortages as well as the tools and approaches to overcome them.

Matt Sample, senior vice president of manufacturer, quality, and replenishment operations at Cencora, joins Over the Counter to discuss key updates under the DSCSA that independent pharmacies need to look out for in 2026.

Tim Drapeau, CEO of CLIAwaived Inc, joined Over the Counter to discuss the Test Yourself @ Home tool and how it is bridging care gaps between patients, pharmacists, and other providers.